DOI QR코드

DOI QR Code

체강액의 세포학

The Cytopathology of Body Cavity Fluid

  • 발행 : 2008.09.30

초록

Cytologic examination of the body cavity fluid is very important because the specimens represent a significant percentage of nongynecologic samples and this cytologic examination may be the first, best or only chance for making the diagnosis of an underlying malignancy. The purposes of body cavity fluid examination are to correctly identify cancer cells and if possible, to identify the tumor types and primary sites when presented with unknown primary tumor sites. The most important basic differential diagnosis is that of benign and reactive disease vs malignant disease. Reactive mesothelial cells are a consistent population in body cavity fluid, and these are the most versatile cells in the body. Due to the specific environment of the body cavity, the exfoliated reactive mesothelial cells may show significant morphologic overlap with the morphology of cancer cells. With a focus on the differential points between reactive mesothelial cells and metastatic adenocarcinoma cells, the practical diagnostic approaches, the diagnostic clues and the pitfalls to achieve a correct diagnosis are presented in this review.

키워드

참고문헌

  1. Shidham VB, Atkinson BF. Cytopathologic Diagnosis of Serous Fluids. Philadelphia: Saunders-Elsevier; 2007
  2. Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U, Bocking A. Diagnostic accuracy of effusion cytology. Diagn Cytopathol 1999;20:350-357 https://doi.org/10.1002/(SICI)1097-0339(199906)20:6<350::AID-DC5>3.0.CO;2-7
  3. Wilbur DC. Body cavity fluid examination: Problem patterns and their resolution. Syllabus, 2006 College of American Pathologists
  4. Churg A, Cagle PT, Roggli VL. Tumors of the serosal membranes. AFIP atlas of tumor pathology. 4th series, Fascicle 3, 2006
  5. Pereira TC, Saad RS, Liu Y, Silverman JF. The diagnosis of malignancy in effusion cytology: A pattern recognition approach. Adv Anat Pathol 2006;13:174-184 https://doi.org/10.1097/00125480-200607000-00004
  6. Moriaty AT, Stastny J, Volk EE, et. al. Fluids-Good and Bad Actors. Observation from the College of American Pathologists interlaboratory comparison program in nongynecoloic cytology. Arch Pathol Lab Med 2004;128:513-518
  7. Cibas ES, Ducatman BS. Cytology. Diagnostic principles and clinical correlates. Philadelphia: Saunders-Elsevier; 2007, pp119-44
  8. Mohanty SK, Dey P. Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 2003;79:569-574 https://doi.org/10.1136/pmj.79.936.569
  9. Choi S, Kang MS. The diagnostic utility of mesothelial markers in distinguishing between reactive mesothelial cell and adenocarcinoma cells in serous effusions with cytospin preparation. Korean J Cytopathol 2006; 17:108-115
  10. Choi YD, Kim JH, Kim G et al. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks. The Proceedings of the 22th Annual Spring Meeting of the Korean Society for Cytopathology, 2008, p39